Table 2. Motifs in TRPV1 5'UTR.
| TRPV1v0 | ||||
|---|---|---|---|---|
| No. | RegRNA ID | Location | Length (nt) | Sequence |
| 1 | TOP | 53-63 | 11 | CTCTCCCTTCG |
| 2 | GAIT | 74-98 | 25 | CGGTTGCTACTGAAGGGAGAGCTG |
| 107-134 | 28 | GTGTGCCTGCGTCAGCTGGTTGCACAC | ||
| TRPV1v1 | ||||
|---|---|---|---|---|
| No. | RegRNA ID | Location | Length (nt) | Sequence |
| 1 | TOP | 117~121 | 5 | CTCTG |
| 147~151 | 5 | CCCTG | ||
| 178~184 | 7 | CTCCCCG | ||
| 232~237 | 6 | CTTCTG | ||
| 2 | uORF | 97~174 | 78 | ATGACAGTGTGATGGAGAGTCTCTGCCGTGC |
| CATCTGGGATGCAAACCGTCCCTGTGT | ||||
| TCCCCACGTCCAGGCCGTAG | ||||
| TRPV1v3 | ||||
|---|---|---|---|---|
| No. | RegRNA ID | Location | Length (nt) | Sequence |
| 1 | TOP | 39~46 | 8 | CTCTTCTG |
| 73~80 | 8 | CCTCCCTG | ||
| 101-105 | 5 | CCCCG | ||
| 114-118 | 5 | CCTTG | ||
| 161-165 | 5 | CCCTG | ||
| 228-232 | 5 | CTCTG | ||
| 290-294 | 5 | CCCTG | ||
| 308-313 | 6 | CCTCTG | ||
| 317-322 | 6 | CCTCTG | ||
| 398-402 | 5 | CCCTG | ||
| 413-418 | 6 | CCCTTG | ||
| 459-463 | 5 | CTTTG | ||
| 472-476 | 5 | CCCCG | ||
| 2 | uORF | 201-314 | 114 | ATGGGTCTAACCCAGAACCACAGATGGCTC |
| TGAGCCGGGGGCCTGTCCACCCTCCCAGGC | ||||
| CGACGTCAGTGGCCGCAGGACTGCCTGGGC | ||||
| CCTGCTAGGCCTGCTCACCTCTGA | ||||
| 3 | GAIT | 27-51 | 25 | CAGTCTGCTTGGCTCTTCTGGACTG |
| 110-134 | 25 | TTTTCCTTGTTCTGTGTGGGGAGGG | ||
| 110-136 | 27 | TTTTCCTTGTTCTGTGTGGGGAGGGAG | ||
| 110-137 | 28 | TTTTCCTTGTTCTGTGTGGGGAGGGAGG | ||
| 392-416 | 25 | GGGGTACCCTGCTTCACAGGGCCCT | ||
| 438-465 | 28 | TCTAAGGACAAGCAGTCCTTACTTTGGG | ||
| 109-133 | 25 | CGGCCGGGGTGGCTGTCGTGGGCTG | ||
| TRPV1v4 | ||||
|---|---|---|---|---|
| No. | RegRNA ID | Location | Length (nt) | Sequence |
| 1 | TOP | 64-70 | 7 | CTTCCTG |
| 156-160 | 5 | CTCCG | ||
| 2 | uORF | 43-165 | 123 | ATGATAGCACAATCCCGGCTGCTTCCTGTT |
| GGCTGGGTTTGGTTGGACTGGGACCCGTCA | ||||
| GAGGAAAAGGCAACGCCGCTGACAAAGAAC | ||||
| ATTGCCGAAAGGTTCATGGGAGGCTCCGGCTAA | ||||
| 4 | GAIT | 19-44 | 26 | ATTCAGCGTTTGTCGACTGACTGAAT |
RegRNA ID are represented, Location (as nucleotide position in 5'UTR mRNA region, Length in bases (b) and the relative nucleotide sequence. Terminal Oligopyrimidine Tract (TOP), Gamma Interferon activated inhibitor of Ceruloplasmin mRNA translation (GAIT), Upstream Open Reading Frame (uORF), Internal Ribosome Entry Site (IRES).